UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antivirals in medical biodefense

Virus genes, 2020-04, Vol.56 (2), p.150-167

2020

Volltextzugriff (PDF)

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib

Alimentary pharmacology & therapeutics, 2011-10, Vol.34 (8), p.949-959

2011

Volltextzugriff (PDF)

P0385 : Prognostic impact of the Baveno IV staging system of portal hypertension in patients with cirrhosis and hepatocellular carcinoma

Journal of hepatology, 2015-04, Vol.62, p.S457-S457

2015

Volltextzugriff (PDF)

Survival Rate in a Large Austrian Cohort of Chronic Hepatitis C Patients

Journal of hepatology, 2016, Vol.64 (2), p.S342-S343

2016

Volltextzugriff (PDF)

P1280 EPIDEMIOLOGICAL TRENDS OF HEPATOCELLULAR CARCINOMA IN AUSTRIA

Journal of hepatology, 2014-04, Vol.60 (1), p.S516-S516

2014

Volltextzugriff (PDF)

P0362 : Hepatocellular carcinoma incidence in chronic hepatitis C patients according to antiviral treatment status

Journal of hepatology, 2015-04, Vol.62, p.S446-S447

2015

Volltextzugriff (PDF)

O050 : A new algorithm for predicting the hepatocellular carcinoma occurrence in cirrhotic patients

Journal of hepatology, 2015-04, Vol.62, p.S216-S217

2015

Volltextzugriff (PDF)

O055 : Pushing the limits for tace: Selection for transarterial chemoembolisation treatment (state) score identifies HCC patients at BCLC stage C suitable for tace

Journal of hepatology, 2015-04, Vol.62, p.S219-S219

2015

Volltextzugriff (PDF)

983 INCIDENCE AND MORTALITY TRENDS FOR BILIARY TRACT CANCERS IN AUSTRIA

Journal of hepatology, 2013-04, Vol.58, p.S405-S405

2013

Volltextzugriff (PDF)

O125 HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN CHRONIC HEPATITIS C PATIENTS (CHC) ACCORDING TO SUSTAINED VIROLOGIC RESPONSE (SVR) AND BASELINE CHARACTERISTICS

Journal of hepatology, 2014-04, Vol.60 (1), p.S52-S52

2014

Volltextzugriff (PDF)

P983 VALIDATION OF THE HEPATOME ARTERIAL-EMBOLIZATION PROGNOSTIC (HAP)-SCORE IN AN AUSTRIAN TACE COHORT

Journal of hepatology, 2014-04, Vol.60 (1), p.S402-S403

2014

Volltextzugriff (PDF)

O129 VALIDATION OF THE BCLC-B SUBCLASSIFICATION IN AN AUSTRIAN TACE COHORT

Journal of hepatology, 2014-04, Vol.60 (1), p.S53-S53

2014

Volltextzugriff (PDF)

102 THE ART OF DECISION MAKING: RETREATMENT WITH TACE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

Journal of hepatology, 2013-04, Vol.58, p.S45-S45

2013

Volltextzugriff (PDF)

Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species

Journal of antimicrobial chemotherapy, 1999-05, Vol.43 Suppl B (suppl_2), p.69-76

1999

Volltextzugriff (PDF)

656 OUTCOME OF PATIENTS WITH CHILD-PUGH C LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION

Journal of hepatology, 2011-03, Vol.54, p.S265-S265

2011

Volltextzugriff (PDF)

THU-099 - Survival Rate in a Large Austrian Cohort of Chronic Hepatitis C Patients

Journal of hepatology, 2016, Vol.64 (2), p.S342-S343

2016

Volltextzugriff (PDF)

The impact of platelets on patients with hepatocellular carcinoma

Journal of hepatology, 2018-04, Vol.68, p.S429

2018

Volltextzugriff (PDF)

FRI-153 - The impact of platelets on patients with hepatocellular carcinoma

Journal of hepatology, 2018-04, Vol.68, p.S429-S429

2018

Volltextzugriff (PDF)

Incidence and mortality trends for biliary tract cancers in Austria

Zeitschrift für Gastroenterologie, 2013-05, Vol.51 (5)

2013

Volltextzugriff (PDF)

A new algorithm for predicting the hepatocellular carcinoma occurrence in cirrhotic patients

Zeitschrift für Gastroenterologie, 2015, Vol.53 (5)

2015

Volltextzugriff (PDF)

Use of inhibitors of the renin angiotensin system is associated with longer survival in patients with hepatocellular carcinoma

Zeitschrift für Gastroenterologie, 2017, Vol.55 (5), p.e28-e56

2017

Volltextzugriff (PDF)

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib: HCC: prognostic factors for sorafenib therapy

Alimentary pharmacology & therapeutics, 2011-10, Vol.34 (8), p.949-959

2011

Volltextzugriff (PDF)

The ART-strategy: Sequential assessment of the ART-score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE

Zeitschrift für Gastroenterologie, 2013, Vol.51 (5)

2013

Volltextzugriff (PDF)

Clinical characteristics of patients with hepatocellular carcinoma in Austria - Is there a need for a structured screening program?

Zeitschrift für Gastroenterologie, 2011, Vol.49 (5)

2011

Volltextzugriff (PDF)

Outcome of patients with Child-Pugh C liver cirrhosis and hepatocellular carcinoma after liver transplantation

Zeitschrift für Gastroenterologie, 2011, Vol.49 (5)

2011

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(71)

Publikationsform

Sprache

Englisch
(65)
Deutsch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antivirals in medical biodefense

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib

P0385 : Prognostic impact of the Baveno IV staging system of portal hypertension in patients with cirrhosis and hepatocellular carcinoma

Survival Rate in a Large Austrian Cohort of Chronic Hepatitis C Patients

P1280 EPIDEMIOLOGICAL TRENDS OF HEPATOCELLULAR CARCINOMA IN AUSTRIA

P0362 : Hepatocellular carcinoma incidence in chronic hepatitis C patients according to antiviral treatment status

O050 : A new algorithm for predicting the hepatocellular carcinoma occurrence in cirrhotic patients

O055 : Pushing the limits for tace: Selection for transarterial chemoembolisation treatment (state) score identifies HCC patients at BCLC stage C suitable for tace

983 INCIDENCE AND MORTALITY TRENDS FOR BILIARY TRACT CANCERS IN AUSTRIA

O125 HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN CHRONIC HEPATITIS C PATIENTS (CHC) ACCORDING TO SUSTAINED VIROLOGIC RESPONSE (SVR) AND BASELINE CHARACTERISTICS

P983 VALIDATION OF THE HEPATOME ARTERIAL-EMBOLIZATION PROGNOSTIC (HAP)-SCORE IN AN AUSTRIAN TACE COHORT

O129 VALIDATION OF THE BCLC-B SUBCLASSIFICATION IN AN AUSTRIAN TACE COHORT

102 THE ART OF DECISION MAKING: RETREATMENT WITH TACE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species

656 OUTCOME OF PATIENTS WITH CHILD-PUGH C LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION

THU-099 - Survival Rate in a Large Austrian Cohort of Chronic Hepatitis C Patients

The impact of platelets on patients with hepatocellular carcinoma

FRI-153 - The impact of platelets on patients with hepatocellular carcinoma

Incidence and mortality trends for biliary tract cancers in Austria

A new algorithm for predicting the hepatocellular carcinoma occurrence in cirrhotic patients

Use of inhibitors of the renin angiotensin system is associated with longer survival in patients with hepatocellular carcinoma

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib: HCC: prognostic factors for sorafenib therapy

The ART-strategy: Sequential assessment of the ART-score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE

Clinical characteristics of patients with hepatocellular carcinoma in Austria - Is there a need for a structured screening program?

Outcome of patients with Child-Pugh C liver cirrhosis and hepatocellular carcinoma after liver transplantation

Suchergebnisse filtern